Expanding Newborn Screening For Victorian Babies
Victorian newborns will now be screened for two additional rare but serious health conditions, helping to identify babies at risk of developing illnesses and making sure they get the lifesaving treatment they need sooner.
Premier Jacinta Allan and Minister for Medical Research Ben Carroll today visited the Murdoch Children’s Research Institute (MCRI) to announce the Newborn Bloodspot Screening Program will now test for spinal muscular atrophy (SMA) and severe combined immunodeficiency (SCID).
Commonly referred to as the heel prick test, the addition of SCID and SMA will see the program test babies for 29 uncommon conditions – making sure parents can get their children early treatment so they live long, healthy lives.
In Victoria, it’s estimated two babies per year will be born with SCID and eight babies a year will be born with SMA.
Weakening the immune system, SCID affects the body’s ability to fight infections due to compromised white blood cells, but early diagnosis and stem cell treatment before three-and-a-half months can be lifesaving.
Identifying newborns with SCID will enable access to a new gene therapy trial delivered by the Murdoch Children’s Research Institute and announced by the Government in 2023 – the first time a cure has been offered in Australia.
SMA is a serious disease-causing progressive muscle wastage and weakness that is life threatening without treatment. While there is currently no cure, early intervention and new treatments are improving outcomes.
The Labor Government has invested more than $1 million to roll out the additional screening, including adding congenital adrenal hyperplasia (CAH) to the program last year. CAH is a serious but treatable condition that affects the production of hormones – if caught early, babies who receive proper treatment can lead full lives.
The program is offered to the parents of all newborns within their first 72 hours of life, at no cost. In 2023, more than 73,000 Victorian newborns were screened.
Newborn bloodspot screening began in Victoria in 1966, with more than 3.6 million babies screened to date – one in 1,000 are found to have a rare, but serious condition such as congenital hypothyroidism and cystic fibrosis.